← Leaderboards
John A Taylor
University Of Kansas Medical Center
$403,840
Attributed
$598,583
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $217.4K · FY2019–24$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$598,583 · 2
By mechanism
R21$389,486 · 1
P30$209,097 · 1
Top collaborators
- Danny R Welch2 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Christine Makosky Daley$16,990,841
- Matthew S. Mayo$3,845,524
- Tara Lin$2,024,441
- Ann M Davis$9,011,995
- Taneisha Shani Scheuermann$1,389,970
Others in their field
Other Emerging Leaders on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,375,181
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,483,553
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,555,721
- Yunda Huang · Fred Hutchinson Cancer Center$54,118,126
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Biological MarkersAreaBasic ScienceGeneticLaboratoriesResponseProgramsClinical TrialsAdultCollaborationsCancer Center Support GrantChildhoodClinical ResearchClinical SciencesAcademiaCitiesCancer PatientAdolescentCancer BiomarkersApplied ResearchCancer TherapyCancer CenterBiomarker ValidationBiomarker Discovery
Grant awards (5)
Regulatory Role of Mitochondrial DNA in Bladder Cancer Progression$172,098
R21 · FY2024 · CA · contact PI
Regulatory Role of Mitochondrial DNA in Bladder Cancer Progression$217,388
R21 · FY2023 · CA · contact PI
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$69,674
P30 · FY2021 · CA · contact PI
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$69,699
P30 · FY2020 · CA · contact PI
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$69,724
P30 · FY2019 · CA · contact PI